SCHEMBL8186027

SCHEMBL8186027

C/C=C/C[C@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458050 1.00 — —
SCHEMBL14388431 1.00 — —
SCHEMBL866068 1.00 — —
SCHEMBL8186028 1.00 — —
SCHEMBL458049 1.00 — —
SCHEMBL13406449 1.00 — —
SCHEMBL15703578 1.00 — —
Hydrochloric Acid SCHEMBL74585 0.98 GRIK1 (0.66) —
Hydrochloric Acid SCHEMBL712566 0.98 GRIK1 (0.66) —
Hydrochloric Acid SCHEMBL713389 0.98 GRIK1 (0.66) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158179-A1 RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF RAYZEBIO, INC. 2023-05-25 — — US disclosed
US-20150148524-A1 AMINO ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS UNIV MONASH (AU) 2015-05-28 — — US disclosed
US-20150148524-A1 AMINO ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS UNIV MONASH (AU) 2015-05-28 — — US disclosed
US-8748570-B2 Insulin analogues SYNGENE LIMITED (AU) 2014-06-10 — — US disclosed
US-8748570-B2 Insulin analogues SYNGENE LIMITED (AU) 2014-06-10 — — US disclosed
US-20120225811-A1 INSULIN ANALOGUES POLYCHIP PHARMACEUTICALS PTY LTD (AU) 2012-09-06 — — US disclosed
US-20120225811-A1 INSULIN ANALOGUES POLYCHIP PHARMACEUTICALS PTY LTD (AU) 2012-09-06 — — US disclosed
WO-2011146972-A1 METHODS FOR THE SYNTHESIS OF DICARBA BRIDGES IN PEPTIDES MONASH UNIVERSITY (AU) 2011-12-01 — — WO disclosed
WO-2011146974-A1 METHODS FOR THE SYNTHESIS OF ALKYNE-CONTAINING DICARBA BRIDGES IN PEPTIDES MONASH UNIVERSITY (AU) 2011-12-01 — — WO disclosed
WO-2011146973-A1 INSULIN ANALOGUES MONASH UNIVERSITY (AU) 2011-12-01 — — WO disclosed
US-6015879-A COMPOUNDS FOR TREATMENT OF NERVOUS SYSTEM DISORDERS INCLUDING ALZHEIMER'S DISEASE, COGNITION DEFECTS, DOWN'S SYNDROME, PARKINSON'S DISEASE, CEREBRAL HEMORRHAGE WITH AMYLOIDOSIS, DEMENTIA PUGILISTICA, AND HEAD TRAUMA SIBIA NEUROSCIENCES, INC. (US) 2000-01-18 — — US disclosed
US-5969100-A Peptide, peptide analog and amino acid analog protease inhibitors SIBIA NEUROSCIENCES, INC. (US) 1999-10-19 — — US disclosed
US-5962419-A NERVOUS SYSTEM DISORDERS; BRAIN DISORDERS SIBIA NEUROSCIENCES, INC. (US) 1999-10-05 — — US disclosed
US-5872101-A Methods of treating neurodegenerative disorders using protease inhibitors SIBIA NEUROSCIENCES, INC. (US) 1999-02-16 — — US disclosed
US-5863902-A Methods of treating neurodegenerative disorders using protease inhibitors SIBIA NEUROSCIENCES, INC. (US) 1999-01-26 — — US disclosed
US-5804560-A MODULATES PROCESSING OF AMYLOID PRECURSOR PROTEIN SIBIA NEUROSCIENCES, INC. (US) 1998-09-08 — — US disclosed
US-5714471-A USEFUL IN INDICATING NEURODEGENERATIVE DISORDERS CHARACTERIZED BY DEPOSITION OF CEREBRAL AMYLOID SIBIA NEUROSCIENCES, INC. (US) 1998-02-03 — — US disclosed
EP-0800528-A1 PEPTIDE AND PEPTIDE ANALOG PROTEASE INHIBITORS Sibia Neurosciences, Inc. (US) 1997-10-15 — — EP disclosed
WO-1996020725-A2 PEPTIDE, PEPTIDE ANALOG AND AMINO ACID ANALOG PROTEASE INHIBITORS SIBIA NEUROSCIENCES, INC. (US) 1996-07-11 — — WO disclosed
WO-1996020949-A1 PEPTIDE AND PEPTIDE ANALOG PROTEASE INHIBITORS SIBIA NEUROSCIENCES, INC. (US) 1996-07-11 — — WO disclosed
Send feedback